Low gamma nuclei to detect muscle disease and therapy
By Philips Featuring Glenn A Walter, PhD and Yi Xia, Philips | April, 2024 | 26:03 min
Webinar highlights - Total duration [26:03]
[01:20] ∙ Comprehensive MR Evaluations of Duchenne Muscular Dystrophy – Proton [08:42] ∙ Duchenne Muscular Dystrophy with Sodium MRI Imaging [10:42] ∙ Phosphorus Spectroscopy [17:12] ∙ Carbon Monitoring of Glycogen Storage Diseases [21:00] ∙ Q&A
Join Dr. Glenn A Walter in this webinar as he explores the exciting therapeutic potential of utilizing low gamma nuclei imaging and spectroscopy with sodium, phosphorus and carbon, alongside proton, to detect muscle diseases. Learn how easy it is to seamlessly integrate workflow for multi-nuclei image acquisition, spectroscopy, reconstruction and viewing.
“Doing sodium imaging can precede fatty degenerative changes. This gives us another way to look at the muscle microstructure which can provide feedback on therapeutics.”
Glenn A Walter, PhD
Professor and Vice-Chair of Physiology and Aging,
University of Florida, Amris,
Gainesville, Florida, USA
Speakers list
Glenn A Walter, PhD
Professor and Vice-Chair of Physiology and Aging,
University of Florida, Amris,
Gainesville, Florida, USA
Yi Xia
Business Marketing Manager,
Clinical & Key Customer Relationships,
Madison, Wisconsin, USA
Register for the Radiology Insights newsletter
Our periodic Radiology Insights newsletter provides you with the latest articles on user experiences and best practices.
